Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-05
1994-09-06
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514357, 514428, 514534, 514563, 546265, 546336, 548561, 560 42, 562451, 562457, A61K 3144, C07D21302
Patent
active
053448367
ABSTRACT:
A fused benzenoxyacetic acid derivative of the formula (I): ##STR1## and salts thereof possess an agonistic on PGI.sub.2 receptor, so it is useful for prevention and/or treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer and hypertention.
REFERENCES:
Nature, vol. 263, Oct. 21, 1976, pp. 663-665.
Prostaglandins, vol. 12, No. 5, Nov. 1976, pp. 685-713.
Prostaglandins, vol. 12, No. 6, Dec. 1976, pp. 915-928.
Prostaglandins, vol. 13, No. 3, Mar. 1977, pp. 375-388.
Chemical & Engineering News, Dec. 20, 1976, pp. 17-19.
Br. J. Pharmac. 76, 1982, pp. 423-438.
Br. J. Pharmac. 84, 1985, pp. 595-607.
Br. J. Pharmac. 102, 1991, pp. 251-265.
Hamanaka Nobuyuki
Takahashi Kanji
Tokumoto Hidekado
Davis Zinna N.
Ivy C. Warren
Ono Pharmaceutical Co. Ltd.
LandOfFree
Fused benzeneoxyacetic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused benzeneoxyacetic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused benzeneoxyacetic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1329647